Cost of Acute and Sequelae Care for Japanese Encephalitis Patients, Bangladesh, 2011-2021.
Bangladesh
Japanese
Japanese encephalitis
Japanese encephalitis vaccines
cost of illness
encephalitis virus
viruses
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
medline:
22
11
2023
pubmed:
21
11
2023
entrez:
21
11
2023
Statut:
ppublish
Résumé
Japanese encephalitis (JE) is associated with an immense social and economic burden. Published cost-of-illness data come primarily from decades-old studies. To determine the cost of care for patients with acute JE and initial and long-term sequelae from the societal perspective, we recruited patients with laboratory-confirmed JE from the past 10 years of JE surveillance in Bangladesh and categorized them as acute care, initial sequalae, and long-term sequelae patients. Among 157 patients, we categorized 55 as acute, 65 as initial sequelae (53 as both categories), and 90 as long-term sequelae. The average (median) societal cost of an acute JE episode was US $929 ($909), of initial sequelae US $75 ($33), and of long-term sequelae US $47 ($14). Most families perceived the effect of JE on their well-being to be extreme and had sustained debt for JE expenses. Our data about the high cost of JE can be used by decision makers in Bangladesh.
Identifiants
pubmed: 37987586
doi: 10.3201/eid2912.230594
pmc: PMC10683813
doi:
Substances chimiques
Japanese Encephalitis Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2488-2497Subventions
Organisme : Bill & Melinda Gates Foundation
ID : INV-008523
Pays : United States
Références
Cost Eff Resour Alloc. 2005 Jan 19;3(1):1
pubmed: 15659245
Soc Sci Med. 2006 Feb;62(4):858-65
pubmed: 16099574
Vaccine. 2012 Aug 10;30(37):5569-77
pubmed: 22698453
Southeast Asian J Trop Med Public Health. 2001 Dec;32(4):682-8
pubmed: 12041539
Emerg Infect Dis. 2009 Jan;15(1):1-7
pubmed: 19116041
Vaccine. 2010 Jun 23;28(29):4593-9
pubmed: 20470803
Am J Trop Med Hyg. 2010 Feb;82(2):344-9
pubmed: 20134015
Bull World Health Organ. 2010 Aug 1;88(8):584-92
pubmed: 20680123
Bull World Health Organ. 2011 Oct 1;89(10):766-74, 774A-774E
pubmed: 22084515
Int J Infect Dis. 2020 Oct;99:69-74
pubmed: 32721530
PLoS Negl Trop Dis. 2021 Jun 21;15(6):e0009505
pubmed: 34153039
J Neurol Neurosurg Psychiatry. 2000 Apr;68(4):405-15
pubmed: 10727474
PLoS Negl Trop Dis. 2015 Mar 20;9(3):e0003630
pubmed: 25794009
Soc Sci Med. 1997 Jun;44(12):1781-90
pubmed: 9194240
J Trop Med Hyg. 1981 Feb;84(1):41-4
pubmed: 6259374
J Trop Pediatr. 2001 Apr;47(2):98-105
pubmed: 11336143
Bull World Health Organ. 2003;81(5):334-42
pubmed: 12856051
PLoS Negl Trop Dis. 2021 Jun 11;15(6):e0009439
pubmed: 34115764
Braz J Infect Dis. 2012 Nov-Dec;16(6):564-73
pubmed: 23141974
PLoS Negl Trop Dis. 2013 Sep 12;7(9):e2383
pubmed: 24069467